A multicenter case-control study in Iran reported that self-reported prolonged mobile phone use was associated with higher odds of confirmed and suspected breast cancer status. The authors emphasize that the findings do not imply causation and note limitations including self-reported exposure and potential residual confounding. They call for larger prospective studies with objective exposure assessment.

RF Safe argues that Media Bias/Fact Check (MBFC) downgraded RF Safe partly by citing an FDA webpage stating typical RF exposure is not supported by current evidence as a health risk, but that the cited FDA page now redirects to a general “Cell Phones” landing page. The post claims other historically cited FDA consumer pages also redirect and that the strongest reassurance language is now mainly accessible via archives. It further cites Reuters reporting that FDA removed outdated webpages about cellphone safety alongside HHS launching a new study, and contends MBFC should update its rationale and links.

This RF Safe commentary argues that HHS, under Secretary Robert F. Kennedy Jr., was correct to remove FDA webpages that gave broad assurances that cell phone radiation is “not dangerous.” It claims blanket safety messaging is scientifically indefensible given animal toxicology findings (notably the U.S. National Toxicology Program studies), a WHO-commissioned systematic review of animal cancer studies (Mevissen et al., 2025), and references to federal court findings. The piece frames the change as a precautionary, science-based correction rather than an anti-science move.

This RF Safe commentary argues that Reuters-reported actions by HHS and FDA—launching an HHS study and removing older FDA webpages stating cellphones are “not dangerous”—should be understood as a risk-communication/scientific-integrity adjustment rather than a declaration of confirmed harm. It contends that categorical safety messaging is not justified given mixed evidence, citing the D.C. Circuit’s 2021 decision criticizing FCC reliance on conclusory FDA statements, along with selected human, animal, and mechanistic literature. The post calls for more uncertainty-aware, evidence-graded public messaging about RF exposure from phones.

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review (Mevissen et al., 2025) as motivation, emphasizing reported tissue-selective findings and non-monotonic dose patterns. The post proposes a mechanistic framework (“S4–Mito–Spin”) and calls for research to map boundary conditions across tissues and exposure parameters to inform standards beyond SAR/thermal assumptions.

This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard control) and signals a shift from definitive safety messaging toward renewed inquiry, while noting that details of any planned research have not been publicly disclosed. The piece also highlights Kennedy’s past public statements alleging harms from Wi‑Fi/5G and links the policy context to the 2021 D.C. Circuit remand of FCC RF policy.

RF Safe reports that HHS confirmed plans to launch a new study on cellphone radiation and that an HHS spokesperson said the FDA removed webpages with “old conclusions” while new research is undertaken to identify knowledge gaps, including for emerging technologies. The article frames the FDA webpage changes as a meaningful shift away from categorical reassurance, while noting Reuters’ reporting that some FDA and CDC pages still state there is no credible evidence of health problems from cellphone radiation. It also links the development to the 2021 D.C. Circuit decision in Environmental Health Trust v. FCC, arguing the ruling exposed weaknesses in the FCC’s reliance on other agencies’ statements.

RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), emphasizing research, monitoring, and public information rather than definitive safety conclusions. It also links the change to a reported HHS announcement of a new study and portrays the update as a shift toward greater transparency, while noting some safety language may remain on the page.

RF Safe recounts a timeline of FTC actions and consumer guidance targeting phone “radiation shield” stickers/patches that claimed large reductions in exposure, arguing these products can create a false sense of security. The post cites the FTC’s February 2002 enforcement actions and consumer alert, including references to Good Housekeeping Institute testing that reportedly found the products did not reduce exposure. RF Safe also claims it warned about such scams earlier (late 1990s), framing this as its own account rather than an FTC-attributed origin story.

RF Safe promotes its QuantaCase (also called TruthCase) as a leading “anti-radiation” phone case for 2026, emphasizing a directional shielding design intended to deflect RF energy away from the body. The article argues the product aligns with consumer-safety guidance such as keeping phones away from the body and using hands-free modes, and it claims RF Safe’s earlier advocacy influenced FTC/FCC warnings about ineffective or counterproductive shielding products. It cites comparisons, user reviews, and an “independent” 2017 TV review as support, but presents limited verifiable technical detail in the excerpt.

RF Safe publishes a commentary disputing Media Bias Fact Check’s (MBFC) labeling of RF Safe as “pseudoscience” with “mixed factual reporting” and “low credibility.” The post argues MBFC mischaracterized RF Safe’s content as overstating evidence about cell phones and health, claiming RF Safe generally uses cautious, study-referencing language (e.g., “associations,” “potential risks”) and avoids asserting direct human causation. It also points to RF Safe disclaimers that the site is educational and not medical advice, and highlights its research library linking to primary studies such as NTP and Ramazzini animal findings.

This magazine article discusses the rising incidence of thyroid cancer and raises the possibility of an association with increased smartphone use and related RF EMF exposure near the head and neck. It characterizes EMF exposure from personal electronics as a growing public health concern. The piece calls for more research, monitoring, and public awareness, and mentions precautionary measures.

RF Safe argues that a potential MrBeast-branded mobile service (“Beast Mobile”) could drive high adoption among children and therefore raises ethical concerns about children’s exposure to radiofrequency (RF) emissions from always-on, body-worn devices. The post claims the scientific and legal context has shifted and contends that relying on existing regulatory compliance is insufficient, urging a “LiFi compatibility plan” as an exposure-reduction alternative. It cites modeling literature about potentially higher localized absorption in children and references a 2025 systematic review it says found increased cancer incidence in RF-exposed experimental animals, while framing the overall situation as negligence if child-focused marketing proceeds without additional safeguards.

An RF Safe commentary argues that persistent, pulsed “non-native” RF electromagnetic noise can disrupt biological “timing coherence,” leading to downstream “fidelity losses,” particularly in electrically active tissues. It also emphasizes that smartphones are adaptive RF systems that change transmit power and modulation, so accessories that detune antennas or distort near-field conditions may cause phones to transmit harder. The piece cites FTC warnings that partial-shield products can be ineffective and may increase emissions by interfering with signal quality, and it argues that material shielding claims do not directly translate to real-world exposure outcomes.

RF Safe argues that common marketing claims for anti-radiation phone cases (e.g., “99% shielding”) are misleading because they often rely on controlled lab fabric tests that do not reflect real-world phone use. The post claims factors like shield orientation, phone transmit-power increases under obstruction, frequency differences (including 5G bands), and user/body interactions can reduce or even reverse purported exposure reductions. It also criticizes current regulatory testing frameworks for not requiring phones to be tested with cases and promotes RF Safe’s own “TruthCase/QuantaCase” approach as a more honest alternative.

RF Safe argues that radiofrequency (RF) emissions from phones and Wi‑Fi pose non-thermal biological risks and that current safety limits are outdated. The post cites animal studies (including NTP and Ramazzini) and references WHO and IARC positions while promoting a proposed mechanism framework (“S4‑Mito‑Spin”) and calling for regulatory and policy changes. It also includes advocacy claims about regulatory capture and promotes RF Safe products and exposure-reduction practices.

An RF Safe article argues that everyday RF-EMF exposures from phones, Wi‑Fi, and vehicles pose serious health risks, using dramatic framing such as “blood into pancakes.” It cites an ultrasound demonstration and references to a Frontiers in Cardiovascular Medicine paper, WHO reviews, and animal tumor findings, while promoting a proprietary-sounding framework (“S4‑Mito‑Spin”) and proposed solutions like “Clean Ether” tech and LiFi. The piece also calls for policy changes and encourages readers to run self-tests and share results on social media.

This RF Safe article argues that the “strongest” RF-EMF literature supports concern about cancer-related findings, emphasizing non-monotonic dose–response patterns in the U.S. National Toxicology Program (NTP) rat study and citing additional analyses and animal studies. It reports that FDA evaluations have downplayed the human relevance of NTP results due to high exposures and inconsistencies, and counters that some effects may occur at lower exposure levels than commonly claimed. The piece also references the Ramazzini Institute rat study as supportive evidence at lower whole-body SARs and mentions a 2024 PLOS ONE paper analyzing Ramazzini tumors, but provides limited detail in the excerpt.

RF Safe argues that an acute laboratory finding—reported as increased ad-libitum energy intake after brief 3G handset exposure versus sham—supports its proposed “S4 Timing Fidelity” mechanism for non-thermal RF effects. The post links the behavioral outcome to hypothalamic energy-sensing and autonomic changes via voltage-gated ion channel (VGIC) gating perturbations, and further connects this to mitochondrial/oxidative phosphorylation signaling. It also frames electromagnetic hypersensitivity (EHS) as a sensitivity phenotype and proposes testable predictions involving pulse structure and physiological correlates (e.g., HRV, EEG).

This review/technical note discusses whether chronic EMF exposure, mainly from mobile phones and wireless devices, should be reconsidered as a possible risk factor for oral cancer/OSCC. It highlights biological plausibility and reports from pilot cytogenetic and laboratory studies, plus limited epidemiological observations, suggesting increased micronucleus formation and altered stress responses in buccal mucosal cells among long-term users. The authors emphasize that a direct causal link to OSCC is not established and call for more comprehensive research.

This multicenter case-control study in Iran (n=226) examined associations between mobile phone use and breast cancer outcomes in women. Reporting more than 60 minutes/day of phone conversations was associated with higher odds of confirmed invasive breast cancer and of being classified as a suspected case versus <10 minutes/day. The authors emphasize that the results do not establish causation and may be influenced by self-reported exposure and residual confounding, warranting cautious interpretation.

This study assessed whether sleeping with versus without a mobile phone (two-week intervals) affects sleep in medical students, using smartwatch-based monitoring. It reports no statistically significant differences in sleep quality or time spent in wakefulness, REM, light, or deep sleep between conditions. The authors report a statistically significant effect on minimum and average blood oxygen saturation during sleep and call for further research on nightly RF-EMF exposure.

This conference paper uses numerical simulations to evaluate near-field exposure and thermal effects in a detailed human head model from a realistic 5G mobile phone operating at 26 GHz. The preliminary modeling suggests moderate, localized temperature increases in superficial tissues. The authors emphasize the need for higher-resolution models, refined tissue segmentation, longer exposure durations, and varied phone placements to better characterize potential impacts.